BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29787267)

  • 1. Isolation, Synthesis, and Semisynthesis of Amaryllidaceae Constituents from Narcissus and Galanthus sp.: De Novo Total Synthesis of 2- epi-Narciclasine.
    Borra S; Lapinskaite R; Kempthorne C; Liscombe D; McNulty J; Hudlicky T
    J Nat Prod; 2018 Jun; 81(6):1451-1459. PubMed ID: 29787267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkaloid diversity in Galanthus elwesii and Galanthus nivalis.
    Berkov S; Bastida J; Sidjimova B; Viladomat F; Codina C
    Chem Biodivers; 2011 Jan; 8(1):115-30. PubMed ID: 21259423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seasonal accumulation of major alkaloids in organs of pharmaceutical crop Narcissus Carlton.
    Lubbe A; Gude H; Verpoorte R; Choi YH
    Phytochemistry; 2013 Apr; 88():43-53. PubMed ID: 23318143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Narciclasine-4-
    Katoch D; Kumar D; Padwad YS; Singh B; Sharma U
    Nat Prod Res; 2020 Jan; 34(2):233-240. PubMed ID: 30636443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous quantification and identification of Amaryllidaceae alkaloids in Narcissus tazetta by ultra performance liquid chromatography-diode array detector-electrospray ionisation tandem mass spectrometry.
    Katoch D; Sharma U
    J Pharm Biomed Anal; 2019 Oct; 175():112750. PubMed ID: 31330284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Narciclasine - an Amaryllidaceae Alkaloid with Potent Antitumor and Anti-Inflammatory Properties.
    Fürst R
    Planta Med; 2016 Nov; 82(16):1389-1394. PubMed ID: 27542176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of Amaryllidaceae alkaloids in bulbs and tissue cultures of Narcissus papyraceus and four varieties of N. tazetta.
    Tarakemeh A; Azizi M; Rowshan V; Salehi H; Spina R; Dupire F; Arouie H; Laurain-Mattar D
    J Pharm Biomed Anal; 2019 Aug; 172():230-237. PubMed ID: 31060036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of alkaloid accumulation in
    Sidjimova B; Denev R; Nikolova M; Bastida J; Berkov S
    Z Naturforsch C J Biosci; 2024 Mar; 79(3-4):73-79. PubMed ID: 38516999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of Amaryllidaceae Constituents and Unnatural Derivatives.
    Ghavre M; Froese J; Pour M; Hudlicky T
    Angew Chem Int Ed Engl; 2016 May; 55(19):5642-91. PubMed ID: 26969844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudolycorine
    Katoch D; Kumar D; Padwad YS; Singh B; Sharma U
    Nat Prod Res; 2020 Jul; 34(14):2051-2058. PubMed ID: 30784301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineoplastic agents. 550. Synthesis of 10b(s)-epipancratistatin from (+)-narciclasine.
    Pettit GR; Melody N; Herald DL; Knight JC; Chapuis JC
    J Nat Prod; 2007 Mar; 70(3):417-22. PubMed ID: 17346078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antineoplastic agents. 587. Isolation and structure of 3-epipancratistatin from Narcissus cv. Ice Follies.
    Pettit GR; Tan R; Bao GH; Melody N; Doubek DL; Gao S; Chapuis JC; Williams L
    J Nat Prod; 2012 Apr; 75(4):771-3. PubMed ID: 22413911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of haemanthamine as a phytotoxic alkaloid in
    Kempthorne CJ; Borra S; Kumar M; Dokuburra CB; Liscombe DK; McNulty J
    Nat Prod Res; 2023; 37(24):4232-4238. PubMed ID: 36744673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cytochrome P450 liability studies of trans-dihydronarciclasine: a readily available, potent, and selective cancer cell growth inhibitor.
    McNulty J; Thorat A; Vurgun N; Nair JJ; Makaji E; Crankshaw DJ; Holloway AC; Pandey S
    J Nat Prod; 2011 Jan; 74(1):106-8. PubMed ID: 21105682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Narciclasine as an in Vitro Anti-Inflammatory Component of Cyrtanthus contractus by Correlation-Based Metabolomics.
    Rárová L; Ncube B; Van Staden J; Fürst R; Strnad M; Gruz J
    J Nat Prod; 2019 May; 82(5):1372-1376. PubMed ID: 30933514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Narciclasine inhibits angiogenic processes by activation of Rho kinase and by downregulation of the VEGF receptor 2.
    Bräutigam J; Bischoff I; Schürmann C; Buchmann G; Epah J; Fuchs S; Heiss E; Brandes RP; Fürst R
    J Mol Cell Cardiol; 2019 Oct; 135():97-108. PubMed ID: 31381906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid-phase extraction and reversed-phase high-performance liquid chromatography of the five major alkaloids in Narcissus confusus.
    López S; Bastida J; Viladomat F; Codina C
    Phytochem Anal; 2002; 13(6):311-5. PubMed ID: 12494748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinanthus microstephium, an Amaryllidaceae Species with Cholinesterase Inhibitor Alkaloids: Structure-Activity Analysis of Haemanthamine Skeleton Derivatives.
    Adessi TG; Borioni JL; Pigni NB; Bastida J; Cavallaro V; Murray AP; Puiatti M; Oberti JC; Leiva S; Nicotra VE; Garcia ME
    Chem Biodivers; 2019 May; 16(5):e1800662. PubMed ID: 30801949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a Noroxomaritidine Reductase with Amaryllidaceae Alkaloid Biosynthesis Related Activities.
    Kilgore MB; Holland CK; Jez JM; Kutchan TM
    J Biol Chem; 2016 Aug; 291(32):16740-52. PubMed ID: 27252378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of narciprimine from Cyrtanthus contractus (Amaryllidaceae) and evaluation of its acetylcholinesterase inhibitory activity.
    Nair JJ; Aremu AO; van Staden J
    J Ethnopharmacol; 2011 Oct; 137(3):1102-6. PubMed ID: 21787856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.